Synendos Therapeutics AG

https://www.synendos.com

Twitter: @synendos

Synendos Therapeutics is a biopharmaceutical company developing a new class of small molecules aimed at restoring the natural functioning of the endocannabinoid system in the brain with the potential for treating a wide range of Central Nervous System (CNS) disorders. Incorporated in April 2019, Synendos Therapeutics was spun out of the University of Bern and the drug discovery consortium, NCCR TransCure. The company’s novel technology stems from 10 years of solid research on endocannabinoid biology and pharmacology carried out at the University of Bern by co-founders, Professor Jürg Gertsch and Dr Andrea Chicca, and centres around the development of selective endocannabinoid reuptake inhibitors (SERIs). SERIs act by increasing the levels of endogenous cannabinoids in a self-limiting mode of action, representing an innovative and potentially safer therapeutic approach to CNS disorders, associated with anxiety, mood and stress-related disorders, than is currently available. *

	Start	2019-04-01 established (s-off
	Predecessor	University of Bern
	Industry	small-molecule drug
	Industry 2	CNS drug
	Person	Chicca, Andrea (Synendos Therapeutics 202011 CEO + Co-Founder)

	Region	Switzerland_oo
	Country	Switzerland
	Street	24 Gewerbestr.
	City	4123 Allschwil BL
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Synendos Therapeutics AG. (11/12/20). "Press Release: Synendos Therapeutics Raises CHF 20 Million in Series A Financing". Basel.

		Record changed: 2020-11-12

Picture [iito] Plain Stupid Simple 650x80px

More documents for Synendos Therapeutics AG

[1] Synendos Therapeutics AG. (11/12/20). "Press Release: Synendos Therapeutics Raises CHF 20 Million in Series A Financing". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]